期刊文献+

重庆市南川区帕金森病临床特征及诊治现状研究

Clinical features and status quo of Parkinson′s disease diagnosis and treatment in Nanchuan District of Chongqing
下载PDF
导出
摘要 目的分析重庆市南川区帕金森病(PD)患者的临床特征及诊治现状,以指导及推广PD规范化治疗。方法选取2016年9月至2017年10月该院收治的120例PD患者的人口学资料和临床资料,了解其临床特征及诊治现状,指导PD规范化治疗,随访其用药依从性。结果120例患者中改良Hoehn and Yahr分期(H-Y分级)3~5级72例(60.00%),流涎、便秘、嗅觉障碍发生率分别为80.00%(98/120)、90.00%(108/120)、80.00%(96/120)。H-Y分级3~5级、左旋多巴联合多巴胺受体激动剂、每天左旋多巴等效剂量大于或等于400mg是患者症状波动的独立危险因素(P<0.05)。120例患者中所用药物为多巴丝肼72例(60.00%)、苯海索30例(25.00%)。经规范化治疗指导后,85.00%(102/121)的患者症状明显改善。70.00%(84/120)的城镇居民服药依从性较好,60.00%(72/120)的农村患者服药依从性较差。结论重庆市南川区多数PD患者既往未能接受规范化治疗,运动症状较重,非运动症状发生率较高。经规范化治疗后患者症状改善明显,但部分患者服药依从性较差,需长期随访及督促。 Objective To analyze the clinical features and status quo of diagnosis and treatment in the patients with Parkinson′s disease(PD)in Nanchuan District of Chongqing City so as to guide and promote the standardized treatment of PD.Methods The demographic and clinical data of 120 patients with PD treated in this hospital from September 2016 to October 2017 were selected to understand the clinical features and diagnosis and treatment status quo,guide the PD standardized treatment and follow up the medication compliance.Results Among 120 cases,72 cases(60.00%)were the 3-5 stages of modified H-Y classification.The occurrence rates of salivation,constipation and olfactory dysfunction were 80.00%(98/120),90.00%(108/120)and 80.00%(96/120)respectively.The stage 3-5 of H-Y classification,levodopa combined with dopamine receptor agonists(LD+DAs)and daily levodopa equivalent dose(LEDD)≥400 mg were the independent risk factors for the symptoms fluctuation(P<0.05).Among 120 cases,the current drugs were levodopa and benserazide hydrochloride in 72 cases(60.00%)and benzhexol in 30 cases(25.00%).After standardized treatment guidance,85.00%of the patients(102/120)had significant improvement in symptoms.70.00%of urban patients(84/120)had good medication compliance and 60.00%of rural patients(72/120)had medication poor compliance.Conclusion Most PD patients in Nanchuan District of Chongqing City fail to receive the standardized treatment in the past,the motor symptoms are severe,and the incidence rate of non-motor symptoms is high.After standardized treatment,the symptoms of the PD patients are improved significantly,but partial patients have poor medication compliance and need long-term follow-up and supervision.
作者 鲁凤娇 熊联强 犹雪萍 伍绍强 李丹 胡春梅 LU Fengjiao;XIONG Lianqiang;YOU Xueping;WU Shaoqiang;LI Dan;HU Chunmei(Department of Neurology,Affiliated Nanchuan People′s Hospital of Chongqing Medical University,Chongqing 408400,China;Department of General Practice,Affiliated Nanchuan People′s Hospital of Chongqing Medical University,Chongqing 408400,China)
出处 《现代医药卫生》 2021年第6期927-931,共5页 Journal of Modern Medicine & Health
基金 重庆市卫生健康委员会科研项目(2016ZBXM012)。
关键词 帕金森病 诊断 治疗 临床症状 规范 重庆 Parkinson disease Diagnosis Therapy Clinical features Benchmarking Chongqing
  • 相关文献

参考文献13

二级参考文献71

  • 1陈生弟.帕金森病治疗指南[J].中华神经科杂志,2006,39(6):409-412. 被引量:102
  • 2温洪波,张振馨,罗毅,陈生弟,蒋雨平,张小英,孙相如,王新德,姚晨.普拉克索治疗帕金森病的多中心、随机、双盲、溴隐亭对照临床疗效和安全性研究[J].中华神经科杂志,2006,39(9):604-608. 被引量:63
  • 3金雪红,包仕尧.还原型谷胱甘肽合用粉防己碱对帕金森病大鼠抗氧化效应的研究[J].中国临床神经科学,2007,15(2):139-142. 被引量:8
  • 4Grover S, Somaiya M, Kumar S, et al. Psychiatric aspects of Parkinson' s disease [J ]. J Neurosci Rural Pract, 2015,6 ( 1 ) : 65 -76.
  • 5Gibb WR, Lees A. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease [J]. J Neurol Neurosurg Psychiatry, 1988,51 (6) : 745-752.
  • 6Ketharanathan T, HanweUa R, Weerasundera R, et al. Major depressive disorder in Parkinson's disease: a cross-sectional study from Sri Lanka [J]. BMC Psychiatry Psychiatry, 2014, 14 : 278-284 .
  • 7Reijnders JS, Ehrt U, Weber WE, et al. Asystematic review of prevalence studies of depression in Parkinson' s disease [J].Movement Disorders, 2008,23(2) : 183-189.
  • 8Chagas MH, Moriyama TS, Felicio AC, et al. Depression increases in patients with Parkinson's disease according to the increasing severity of the cognitive impairment [J]. Arq Neuropsiquiatr, 2014,72 (6) : 426-429.
  • 9Braak H, Ghebremedhin E, Rub U, et al. Stages in the development of Parkinson's disease related pathology [J]. Cell Tissue Res, 2004,318(1) : 121-134.
  • 10Aarsland D, Pahlhagen S, Ballard CG, et al. Depression in Parkinson disease-epidemiology, mechanisms and management [J]. Nat Rev Neurol, 2011,8(1) :35-47.

共引文献727

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部